Fulcrum Therapeutics
FULC
FULC
168 hedge funds and large institutions have $550M invested in Fulcrum Therapeutics in 2026 Q1 according to their latest regulatory filings, with 36 funds opening new positions, 74 increasing their positions, 38 reducing their positions, and 38 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
16.94% less ownership
Funds ownership: 124.62% → 107.68% (-17%)
28% less capital invested
Capital invested by funds: $763M → $550M (-$213M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
168
Holding in Top 10
1
Calls
$7.41M
Puts
$1.36M
Top Buyers
| 1 | +$12.3M | |
| 2 | +$11.1M | |
| 3 | +$10.5M | |
| 4 |
Aberdeen Group
Edinburgh,
United Kingdom
|
+$8.89M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
+$7.51M |
Top Sellers
| 1 | -$12.1M | |
| 2 | -$11.5M | |
| 3 | -$10.4M | |
| 4 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$9.05M |
| 5 |
SCM
Sio Capital Management
New York
|
-$4.32M |
